• Produktbild: Hormone Therapy in Breast and Prostate Cancer
  • Produktbild: Hormone Therapy in Breast and Prostate Cancer

Hormone Therapy in Breast and Prostate Cancer

Fr. 150.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

28.09.2009

Abbildungen

XIV, 36 illus., schwarz-weiss Illustrationen

Herausgeber

Jordan V. Craig + weitere

Verlag

Humana Press

Seitenzahl

420

Maße (L/B/H)

22.9/15.2/2.4 cm

Gewicht

628 g

Auflage

Softcover reprint of the original 1st ed. 2002

Sprache

Englisch

ISBN

978-1-60761-471-5

Beschreibung

Rezension

From the reviews:

"...takes the reader on a fascinating scientific journey that illustrates how the combination of clinical and basic investigations has realized the first two objectives for both of these prevalent malignancies and, with breast cancer, the promise of being close to prevention." -Foreword by Prof. Elwood Jensen, Professor Emeritus, University of Chicago

"This was a well-written and well-thought-out book on extensive and changing subject matter...the chapter on nonsteroidal antiandrogens is one of the best chapters I've read on the subject. It was very well written and covered the subject thoroughly." -The Annals of Pharmacotherapy

"Hormone Therapy in Breast and Prostate Cancer offers an authoritative state-of-the-art account of the role of hormones in prostate and breast cancer...all of the chapters are extremely useful to both researchers and clinicians. " -Trends in Endocrinology & Metabolism

"I highly recommend this volume for all oncologists who treat these patients and for the laboratory investigators who would like to see how their work is translated to the clinic." -Oncology

"...this is an excellent contemporary review of this field. It will be of interest, in particular, to obviously breast surgeons or urologists with an interest in malignancy and, in particular, those involved in clinical trials." -ANZ J. Surg

“This book, a paperback version of a book originally published in 2002, does a good job of chronicling the history of the major developments in hormone therapy for both breast and prostate cancer. … I would have recommended it then to any medicinal chemist or pharmacologist that was just starting breast or prostate cancer research … . can be useful for people looking for a good introduction to hormone therapy … .” (Ross V. Weatherman, ChemMedChem, Vol. 5, 2010)

“The aim of this book is to trace the origin of endocrine therapy inbreast and prostate cancer … . Overall the book is more detailed than would be expected and is all the better for it. … This was an interesting book which was much more than the title suggests. It was detailed and the coverage broad giving the reader a wealth of information. The reference lists are very comprehensive … . Overall this is a very useful text.” (Heather M. Wallace, BTS Newsletter, Issue 37, Winter, 2010)

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

28.09.2009

Abbildungen

XIV, 36 illus., schwarz-weiss Illustrationen

Herausgeber

Verlag

Humana Press

Seitenzahl

420

Maße (L/B/H)

22.9/15.2/2.4 cm

Gewicht

628 g

Auflage

Softcover reprint of the original 1st ed. 2002

Sprache

Englisch

ISBN

978-1-60761-471-5

Herstelleradresse

Springer-Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

Email: ProductSafety@springernature.com

Kundinnen und Kunden meinen

0 Bewertungen

Informationen zu Bewertungen

Zur Abgabe einer Bewertung ist eine Anmeldung im Konto notwendig. Die Authentizität der Bewertungen wird von uns nicht überprüft. Wir behalten uns vor, Bewertungstexte, die unseren Richtlinien widersprechen, entsprechend zu kürzen oder zu löschen.

Die Bewertungen sind nach Format, Anzahl Sterne und Datum sortiert.

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kund*innen durch Ihre Meinung

Kundinnen und Kunden meinen

0 Bewertungen filtern

  • Produktbild: Hormone Therapy in Breast and Prostate Cancer
  • Produktbild: Hormone Therapy in Breast and Prostate Cancer
  • An Introduction to the Regulation of Sex Steroids for the Treatment of Cancer
    V. Craig Jordan and Barrington J. A. Furr

    Part I. Preclinical Antiestrogens

    Antiestrogens and the Cell Cycle
    Colin K. W. Watts, Owen W. J. Prall, Jason S. Carroll, Nicholas R. C. Wilcken, Eileen M. Rogan, Elizabeth A. Musgrove, and Robert L. Sutherland

    Drug Resistance to Antiestrogens
    Ruth M. O'Regan, Anait S. Levenson, Gale M. England, Kathy A. Yao, Henry D. Muenzner, Hiroyuki Takei, and V. Craig Jordan

    Mechanisms of Liver Carcinogenesis by Antiestrogens
    David H. Phillips

    The Effects of Triphenylethylene Antiestrogens on Parameters of Multistage Hepatocarcinogenesis in the Rat
    Yvonne P. Dragan and Henry C. Pitot

    Preclinical Studies of Raloxifene and Related Compounds
    Robin Fuchs-Young. Pure Antiestrogens, Alan E. Wakeling

    Part II. Antiestrogens: Clinical

    Tamoxifen for the Treatment of Breast Cancer
    V. Craig Jordan

    Clinical Utility of New Antiestrogens
    Ruth M. O'Regan and William J. Gradishar

    Breast Cancer Prevention with Antiestrogens
    Monica Morrow and V. Craig Jordan

    Part III. Inhibition of Estrogen Synthesis

    Aromatase Inhibitors
    Paul E. Goss and Caroline C. Reid

    Clinical Utility of Aromatase Inhibitors
    K. Shenton, Mitchell Dowsett, and Michael Dukes

    LH-RH Agonists for the Treatment of Breast Cancer: Development and Current Status
    Roger W. Blamey

    Part IV. Androgen and Androgen Withdrawal

    Molecular Action of Androgens
    Shutsung Liao, Junichi Fukuchi, and Yung-Hsi Kao

    Steroidal Antiandrogens
    Fritz H. Schröder and Albert Radlmaier

    Nonsteroidal Antiandrogens
    Geert J. C. M. Kolvenbag and Barrington J. A. Furr

    LH-RH Agonist Role in Prostate Cancer Management
    Amir V. Kaisary

    Part V. Perspective on Progress

    Recent Progress in Breast Cancer Research
    V. Craig Jordan and Barrington J. A. Furr